A report by Clearstate

The future of bioprocessing across Asia Pacific

The APAC bioprocessing market was one of the best performing sectors between 2022-2023—growing at about 18% annually—driven by pandemic spending. However, with post-pandemic normalisation and increased cost of financing, this has dropped to a flatline between 2022-2023. We predict the market has reached its lowest point and will bounce back in the coming two years. Overall, the bioprocessing market is expected to grow by about 9% on average during the 2023-2027 forecast period.

This report highlights how covid-19 continues to impact the industry across APAC, the overall customer and product trends in bioprocessing, and the growing role of local companies in driving demand. It offers insight into the potential challenges as countries look to grow this industry.